DRL launches Renvela generic in US, price target at Rs 2200: HDFC Securities News News / News 6 years ago 440 Views comments The pharma major Dr Reddys Laboratories (DRL) has launched kidney disease drug Renvela generic in the US market. How big an opportunity can this be fo... Read more
News China claims India withdrawn troops in Dokalam, silent on plans to build road News / News - 6 years ago
News Nitish has anti-Congress component in his blood, Sushil Kumar Modi says News / News - 6 years ago
Comments